iShares Biotechnology ETF Pattern Recognition On Neck Pattern

IBB Etf  USD 165.51  -0.72  -0.43%   
The pattern recognition module provides an execution environment for On Neck Pattern recognition and related indicators on IShares Biotechnology. Signals here center on pattern recognition signals tied to momentum and continuation alongside volatility and performance references.

Recognition
The function did not generate any output. Please change time horizon or modify your input parameters. This analysis covers fifty data points across the selected time horizon. The function did not return any valid pattern recognition events for the selected time horizon. The On-Neck Pattern may describe IShares Biotechnology bearish continuation signal.

IShares Biotechnology Technical Analysis Modules

Most technical analysis of IShares Biotechnology help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for IShares from various momentum indicators to cycle indicators. When you analyze IShares charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Etf Overview, Methodology & Data Sources

ETF evaluation emphasizes index methodology, tracking difference, and fee drag. The five-year return stands at 2.0%.

Methodology

Unless otherwise specified, data for iShares Biotechnology ETF is derived from fund disclosures (prospectus language, holdings reports, and periodic statements where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on instrument type. iShares Biotechnology ETF market data and reported NAV may reflect delayed updates. Data may be delayed depending on reporting sources and market conventions. Premium/discount dynamics for iShares Biotechnology ETF can be shaped by underlying holdings liquidity, rebalancing schedules, and market-wide risk appetite. Assumptions: Macroaxis analytics incorporate public fund disclosures, holdings reports, and market data feeds and official disclosures from U.S. Securities and Exchange Commission (SEC) via EDGAR. Data harmonization may result in minor timing offsets. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.

Research Sources

iShares Biotechnology ETF may have reference inputs that incorporate holdings disclosures, category classification, and NAV-derived statistics where available. Updates may occur throughout the day.

This content is curated and reviewed by:

Michael Smolkin - Member of Macroaxis Board of Directors
Last reviewed on March 13th, 2026

Become your own money manager

Tracking IShares Biotechnology inside a portfolio is useful because individual winners can still weaken diversification or distort overall risk targets. That means looking at contribution to return, volatility, and correlation rather than relying on price movement alone.

Did you try this?

Run Price Exposure Probability Now

   

Price Exposure Probability

Analyze equity upside and downside potential for a given time horizon across multiple markets
All  Next Launch Module

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Cash Cows Idea
Cash Cows
Invested few shares
Macroaxis Index Idea
Macroaxis Index
Invested over 60 shares
Driverless Cars Idea
Driverless Cars
Invested over 40 shares
Momentum Idea
Momentum
Invested few shares
Investor Favorites Idea
Investor Favorites
Invested over 20 shares
Hedge Favorites Idea
Hedge Favorites
Invested few shares
Artificial Intelligence Idea
Artificial Intelligence
Invested few shares
Warren Buffett Holdings Idea
Warren Buffett Holdings
Invested few shares
SRI Sustainable Growth Idea
SRI Sustainable Growth
Invested few shares
Baby Boomer Prospects Idea
Baby Boomer Prospects
Invested over 20 shares
Blockchain Idea
Blockchain
Invested few shares
Advertising Idea
Advertising
Invested few shares

More Resources for IShares Etf Analysis

Reviewing iShares Biotechnology ETF commonly begins with financial statements and performance trends. IShares Biotechnology's financial ratios translate raw accounting data into comparable profitability and efficiency signals. Selected reports below provide context for IShares Etf:
IShares Biotechnology has a market cap of 9.22 B. Use Risk vs Return Analysis to explore allocation context. This suggests a position in iShares Biotechnology ETF within the allocation view. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
IShares Biotechnology currently shows P/E of 3.16, market cap of 9.22 Billion. This analysis of IShares Biotechnology works best as a complementary layer when evaluating how the security fits in a broader portfolio. IShares Biotechnology analysis across multiple dimensions - risk, valuation, diversification - produces a more informed position-sizing decision. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Understanding iShares Biotechnology ETF includes distinguishing between market value and book value, where book value reflects IShares's accounting equity. IShares Biotechnology's market capitalization is 9.22 B. At P/B 3.39, IShares Biotechnology trades at a significant premium to book value. The intrinsic value concept focuses on underlying worth, which can diverge from market price and book value. Valuation work aligns these measures into a single context.
Note that IShares Biotechnology's intrinsic value and market price are different measures derived from different inputs. For IShares Biotechnology, key inputs include a P/E ratio of 3.16, and a P/B ratio of 3.39. In practice, IShares Biotechnology price is set by the continuous auction process on its listing exchange.